Higher-Risk Myelodysplastic Syndromes: Lacking Treatment Advances in Over a Decade
May 4th 2020
Continued research is critical to potentially bring a targeted therapeutic option to patients with higher-risk myelodysplastic syndromes, to improve overall survival, manage symptoms, and preserve quality of life.